What stage does Iaso Ventures invest at?

Iaso Ventures invests at the Seed, Series A stages.

Where is Iaso Ventures located?

Iaso Ventures is headquartered in Cambridge, US.

Iaso Ventures

Venture capital

Cambridge · Seed–Series A · 12 people tracked

Also known as IASO VENTURES MANAGEMENT FIRM LLC

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Iaso Ventures invests in game-changing life sciences and healthcare startups working to cure disease and improve patient outcomes. The firm backs data-driven enabling technologies and platforms that support next-generation therapeutic development. Drawing on an investor-operator background and a collaborative, industry-wide approach, Iaso leverages deep sector expertise to accelerate growth and create value. Its mission centers on pursuing the bleeding edge of healthcare innovation while staying grounded in serving patients and maximizing well-being.

Invests inAI & Machine Learning Biotech Digital Health Healthtech Longevity Medical DevicesBostonCambridgeUnited States

Source: firm website, verified Aug 11, 2026.

Stage

Seed–Series A

Cambridge, Massachusetts, US

Instruments

Equity

Founded

2019

Last 12 months

1 investment

Private fund assets

$37.5M

VC funds

Tracked investments

Team · 12 people

from the firm's website & public directories

Wasim Malik· Managing Partner· Boston, Massachusettsin

Oversees strategy, investments and partnerships at Iaso Ventures. Former first Chief Digital Strategist at Roivant Sciences, longtime MGH/Harvard research faculty and MIT lecturer in neuroscience and machine learning, with an active board and angel-investing portfolio.

w•••@iasoventures.comreveal

John Reynders· Chief Data Scientist & Venture Partnerin

Chief Data Scientist and Venture Partner at Iaso and CTO of portfolio company Prudentia Sciences. Previously held senior data science and informatics leadership roles at Neumora, Alexion, Moderna, AstraZeneca and Johnson & Johnson.

Mark G. Currie· Venture Partnerin

Biopharma leader and pharmacologist, former President and CSO and scientific founder of Cyclerion Therapeutics and R&D leader at Ironwood. Primary inventor of linaclotide (Linzess), with numerous board and advisory roles.

Michael Fenn· Venture Partner· Boston, Massachusettsin 𝕏

Venture Partner sourcing deals and conducting scientific and business due diligence. Also Head of External Innovation at Dewpoint Therapeutics, and formerly Director of Healthcare & Life Sciences at Harvard Innovation Labs and a biomedical engineering professor.

Anil S. Jina· Executive in Residence· San Jose, California, United Statesin

Physician and Executive in Residence with extensive biopharma and digital health experience, including chief medical officer roles and medical leadership at Pfizer, Sanofi, Shire and Akili Interactive.

Chandra Ramanathan· Advisor, Biotech· Cambridge, Massachusetts, United Statesin

Advises Iaso on life sciences innovation including drug discovery, delivery and biomanufacturing. Also VP and Head of External Innovation at Danaher, with prior open-innovation leadership at Bayer, Wyeth and Bristol Myers Squibb.

Maurizio Fava· Advisor, Clinical R&D· Boston, Massachusetts, United Statesin

Psychiatrist-in-Chief at Massachusetts General Hospital and Harvard Medical School professor, a world leader in depression research who founded the MGH Clinical Trials Network and Institute.

Noah J. Richmond· Advisor, Legal & IPin

Technology attorney and business strategist with over 15 years building technology platforms. Held legal and regulatory leadership roles at Google, Motorola ATAP and Verily Life Sciences, with a focus on neuroscience innovation.

Raymond Sanchez· Advisor, Drug Development

Psychiatrist and drug development advisor, currently Senior Advisor at Bain Capital Life Sciences and former Chief Medical Officer of Cerevel Therapeutics, with extensive CNS/neuropsychiatry regulatory and development experience.

Sadiqa Mahmood· Entrepreneur in Residence· Boston, MA and Houston, TXin

Physician and Entrepreneur in Residence focused on unmet needs across disease areas and technology-enabled therapeutic development. Formerly SVP and GM of the Life Sciences business at Health Catalyst.

Sharon Tan· Executive in Residencein

Executive in Residence with over 20 years in clinical and preclinical development and pipeline strategy, focused on rare diseases and gene therapy, with prior program leadership at Garuda Therapeutics, enGene, Ultragenyx and Sanofi Genzyme.

Steven Schachter· Advisor, Medtechin

Chief Academic Officer for CIMIT and Harvard Medical School neurology professor, past president of the American Epilepsy Society, focused on accelerating medical technologies from bench to commercialization.

What they invest in

from 14 of 26 portfolio companies

Biotech ×9Healthtech ×8Medical Devices ×6Data & Infrastructure ×3Deep Tech ×3Digital Health ×3AI & Machine Learning ×2SaaS ×2

HQs:United States×11Canada×1

Investments · 26 tracked

founders shown can be your intro path

By year:2026 · 1 2025 · 1 2024 · 1 2021 · 14 dated

CertaraNASDAQ: CERTApr 2026SEC filingmedium confidence

BiotechHealthtechRadnor, US

John Gallagher III(SVP and Chief Financial Officer)Adrian McKemey(President, Certara Drug Development Solutions)Rona Anhalt(Chief Human Resources Officer)Daniel Corcoran(SVP and General Counsel)Robert Aspbury(President, Certara Predicitive Technologies)Leif Pedersen(President, Chief Commercial Officer)

Board seatJohn Reynders· per SEC Form D · filed Apr 2026

Sea PharmaceuticalsJul 2025SEC filingmedium confidence

BiotechCambridge, US

James P. Pearson(PRESIDENT, CHIEF EXECUTIVE OFFICER, CHIEF SCIENCE OFFICER)Michael Higgins(Manager)Eric Olson(Manager)W. Kendall Brown(Manager)Benjamin Cravatt(Manager)Eduardo J. Martinez(Vice President)

Board seatMark G. Currie· per SEC Form D · $1.7M raise · filed May 2026

Aerskaaerska.comin

Aerska develops RNA interference (RNAi) medicines designed for targeted delivery across the blood-brain barrier to treat, delay, and prevent central nervous system and neurological diseases.

BiotechDeep TechMedical Devices

Stuart Milstein(Co-Founder)Jack O’Meara

Axonis Therapeuticsaxonis.usinOct 2024

Axonis Therapeutics develops medicines targeting KCC2 to restore inhibition in the brain, with a focus on treating neurological disorders including epilepsy and pain.

BiotechMedical DevicesBoston, US

Shane Hegarty(Executive Officer)Jeffrey Imbaro(Executive Officer)Joanna Stanicka(Executive Officer, Director)

BoardCorey . Goodman(Director)Jonathan Leff(Director)Raymond J. Kelleher(Director)

Beacon Biosignals

Boston, US

Jacob A. Donoghue, M.D., Ph.D.(Executive Officer, Director)Jarrett Revels(Executive Officer)Jacob A. Donoghue(Executive Officer, Director, Promoter)

BoardCaitlin Donovan(Director)Pavel Raifeld(Director)Naveen Rao(Director)

Cadence Neurosciencecadenceneuro.comin

Cadence develops a neuromodulation system intended to be a more effective, less invasive treatment for people living with drug-refractory epilepsy.

BiotechDigital HealthHealthtechMedical DevicesSammamish, US

Kent Leyde(Executive Officer, Director, Promoter)Warren Douglas Sheffield(Executive Officer, Director, Promoter)

Catena Biosciencescatenabiosciences.comin 𝕏

Catena develops a conjugation platform for antibody-drug conjugates (ADCs) and multi-payload conjugates used in oncology for solid tumors.

BiotechDeep TechHealthtechMedical DevicesSan Francisco, US

Marco Lobba(Founder)inMatthew Francis(Founder)in

Celericelerihealth.com

Clexbioclexbio.com

Deep 6 AIdeep6.aiin

Data & InfrastructureHealthtechPasadena, US

Wout Brusselaers(Executive Officer, Director)Sondra Pepe(Executive Officer)Christian Duvall(Executive Officer)Antonia Holway(Executive Officer)Doug Cassidy(Executive Officer)Peter Casasanto(Executive Officer)

Epiwatchepiwatch.com

EpiWatch is an FDA-cleared seizure detection app for Apple Watch that monitors for tonic-clonic seizures and sends real-time alerts to users and their caregivers.

Digital HealthHealthtechMedical DevicesBaltimore, US

Dean Papadopoulos(Executive Officer, Director, Promoter)Teresa Prego(Executive Officer, Director)Robert Smith(Director)Nathan Crone(Executive Officer, Director, Promoter)Gregory Krauss(Executive Officer, Director, Promoter)

BoardDaniel Hanley(Director)

Inflection Medicineinflectionmedicine.com

Mensura Healthmensurahealth.com

BiotechWeston, US

Nancy Hsiung(Executive Officer)Charles Keough(Executive Officer, Director)Valentin Gribkoff(Executive Officer, Director)

Neumirna Therapeuticsneumirna.com

Neurauraneuraura.comin 𝕏

Neuraura develops LoOoP, a minimally-invasive bioelectronic platform using patented micro-electrode technology to manage polycystic ovary syndrome and other chronic conditions in women.

BiotechFemTechHealthtechCalgary, CA

Pragma Biopragmabio.com

Prudentia Sciencesprudentiasciences.comin 𝕏

Ryghtryght.aiin

Scaffoldscaffoldtx.com

Soovusoovu.com

Statcounterstatcounter.com𝕏

Statcounter provides website analytics and visitor tracking software that displays traffic data, user behavior, and engagement metrics in a simple interface.

AdTechData & InfrastructureMarketing TechSaaS

Aodhán Cullen(Founder and CEO)

Thumbnail for Neurona Therapeuticsneuronatherapeutics.comin

Tuva Healthtuvahealth.comin 𝕏

Tuva provides infrastructure and data standardization solutions for healthcare analytics teams, enabling them to transform raw healthcare data into analysis-ready datasets.

AI & Machine LearningData & InfrastructureDigital HealthHealthtechSaaSSalt Lake City, US

Aaron Neiderhiser(Founder)inCoco Zuloaga(Founder)in

Zafrenszafrens.cominDec 2021

Zafrens develops a unified drug discovery platform that integrates isolation, imaging, and sequencing workflows to accelerate the identification of therapeutic compounds across modalities.

AI & Machine LearningBiotechDeep TechSan Diego, US

Martin SmrcinainMaina NdunguinSwamy Vijayan(Executive Officer, Director)inYi ZhanginVikas Goelin

BoardJustin Briggs in

Zenith Healthzenithhealth.io

Zeto Inczeto-inc.comin 𝕏

Zeto develops a cloud-based EEG (electroencephalogram) system for rapid neurological diagnosis in hospitals, emergency departments, outpatient clinics, and research settings.

Cloud ComputingHealthtechMedical Devices

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 1

IPOs and acquisitions across the tracked portfolio

CertaraNASDAQ: CERT

Portfolio news

latest coverage across their companies

Transforming Healthcare Data with Tuva Health | Out-Of-Pocket

Tuva Health · outofpocket.health · Mar 23, 2026

Frequently asked questions

What stage does Iaso Ventures invest at?: Iaso Ventures invests at the Seed, Series A stages.
What sectors does Iaso Ventures focus on?: Iaso Ventures focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
Where is Iaso Ventures located?: Iaso Ventures is headquartered in Cambridge, US.

Co-investors · 1

Pioneer

Pioneer Fund is a venture capital firm investing in the top Y Combinator startups.

Firms observed investing alongside Iaso Ventures, from public investor directories. Shared companies are the overlap with Iaso Ventures's recorded portfolio.

Similar investors

Future Positive Capital

Future Positive Capital's portfolio page showcasing companies across health, climate, and deeptech sectors.

Averin Capital

Averin Capital is an investment firm focused on the intersection of technology and health, backing teams building companies in areas such as early disease detection, treatment delivery, personalized care, and medical breakthroughs.

Snatched Ventures

Snatched Ventures is a venture capital firm that partners with entrepreneurs pursuing bold, transformative visions, offering strategic support to help scale breakthrough innovations.

Foresite Capital

Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, backing companies across all stages of growth. It applies a data science-driven approach to invest in businesses leveraging biology and big data to transform healthcare.

CABHI Ventures

CABHI (Centre for Aging + Brain Health Innovation) is a pan-Canadian organization that funds and supports researchers, innovators, and startups working on brain health and aging solutions, and helps healthcare and community organizations adopt them.